Lerøy Seafood Group ASA: Ordinary General Shareholders Meeting held
May 28, 2024 08:13 ET
|
Lerøy Seafood Group ASA
Ordinary General Meeting in Lerøy Seafood Group ASA was held today, 28 May 2024. All items were resolved as proposed in the previously pushlished meeting notice. An english translation of the meeting...
Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering
May 28, 2024 08:12 ET
|
Enlivex Therapeutics Ltd
Single healthcare-focused institutional investor $5 million upfront with up to an additional $10 million of gross proceeds upon the exercise in full of clinical milestone-linked warrants ...
Storaktionærmeddelelse – Olav W. Hansen A/S.
May 28, 2024 08:08 ET
|
Silkeborg IF Invest A/S
Nasdaq Copenhagen Silkeborg, den 28. maj...
Projet Moblan : les forages révèlent des intersections épaisses et des teneurs élevées
May 28, 2024 08:07 ET
|
Sayona Mining
Derniers résultats de 94 nouveaux forages totalisant 20 735 m pour le projet Moblan de Sayona, Québec, Canada, dont les points importants sont les suivants : Pegmatites de la zone sud : 40,70 m @...
Bryan Texas Surpasses $2M Milestone in Surplus Sales
May 28, 2024 08:06 ET
|
GovDeals, Inc.
BRYAN, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- The city of Bryan has recently surpassed $2 million in sales of their surplus assets on GovDeals. GovDeals is the leading online auction platform for...
Form 8.3 - International Distributions Services Plc
May 28, 2024 08:05 ET
|
Jupiter Asset Management
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
May 28, 2024 08:05 ET
|
Outlook Therapeutics, Inc.
LYTENAVA™ (bevacizumab gamma) becomes first ophthalmic formulation of bevacizumab to receive European Commission Marketing Authorization for the treatment of wet AMDEuropean Commission decision...
CARGO Therapeutics to Participate in Upcoming Investor Conferences
May 28, 2024 08:05 ET
|
Cargo Therapeutics, Inc.
CARGO Therapeutics to Participate in Upcoming Investor Conferences
StepStone Group to Present at the Morgan Stanley US Financials, Payments & CRE Conference
May 28, 2024 08:05 ET
|
StepStone Group Inc
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced that Scott Hart, CEO, and Mike McCabe, Head of Strategy, are scheduled to present at the Morgan Stanley...
Longeveron® to Attend BIO International Convention 2024
May 28, 2024 08:05 ET
|
Longeveron
Longeveron to attend BIO 2024, exploring potential partnership and strategic opportunities for its Alzheimer’s disease program.